Advice
Following an abbreviated submission
fosamprenavir (Telzir®) in combination with low dose ritonavir is accepted for use within NHS Scotland for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adolescents and children of six years and above in combination with other antiretroviral medicinal products.
Fosamprenavir is listed in the British National Formulary for Children for the treatment of HIV infection. The Scottish Medicines Consortium has previously accepted this product for use in this indication in adults.
Download detailed advice57KB (PDF)
Medicine details
- Medicine name:
- fosamprenavir (Telzir)
- SMC ID:
- 431/07
- Indication:
- HIV1 in adolescents and children of 6 years and above
- Pharmaceutical company
- GlaxoSmithKline UK Ltd
- BNF chapter
- Infections
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 07 September 2009